Literature DB >> 1921235

[Decreased plasma carnitine in Type I diabetes mellitus].

P Pregant1, G Schernthaner, E Legenstein, L Lienhart, S Bruck, C Schnack, E Kaiser.   

Abstract

Realizing the importance of carnitine for the lipid and carbohydrate metabolism and the possible role for glucose utilization and myocardial function carnitine concentrations in type I and type II diabetic patients in plasma, erythrocytes and 24 h urine were determined. The plasma levels of carnitine were significantly diminished in type I diabetic patients compared to controls, while carnitine concentrations in erythrocytes and 24 h urine did not differ from controls. Plasma carnitine levels did not change significantly during the diurnial profile. No correlation between HbA1c and carnitine levels was observed in the diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921235     DOI: 10.1007/bf01649287

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  35 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Effect of D,L-carnitine on the response of the isolated heart of the rat to ischaemia and reperfusion: relation to mitochondrial function.

Authors:  J M Duan; M Karmazyn
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Colorimetric micro-determination of free fatty acids in plasma.

Authors:  S Laurell; G Tibbling
Journal:  Clin Chim Acta       Date:  1967-04       Impact factor: 3.786

4.  Interaction of carnitine with insulin-stimulated glucose metabolism in humans.

Authors:  E Ferrannini; G Buzzigoli; S Bevilacqua; C Boni; D Del Chiaro; M Oleggini; L Brandi; F Maccari
Journal:  Am J Physiol       Date:  1988-12

5.  [Carnitine deficiency].

Authors:  E Schmidt-Sommerfeld; D Penn
Journal:  Monatsschr Kinderheilkd       Date:  1986-05       Impact factor: 0.323

6.  Carnitine and derivatives in rat tissues.

Authors:  D J Pearson; P K Tubbs
Journal:  Biochem J       Date:  1967-12       Impact factor: 3.857

7.  [Carnitine--biochemistry and clinical aspects].

Authors:  H Böhles
Journal:  Infusionsther Klin Ernahr       Date:  1985-04

8.  Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia.

Authors:  M Maebashi; N Kawamura; M Sato; A Imamura; K Yoshinaga
Journal:  Lancet       Date:  1978-10-14       Impact factor: 79.321

9.  Medium-chain triglycerides induce alterations in carnitine metabolism.

Authors:  C Rössle; Y A Carpentier; M Richelle; W Dahlan; N P D'Attellis; P Fürst; D H Elwyn
Journal:  Am J Physiol       Date:  1990-06

10.  L-carnitine effect on plasma lipoproteins of hyperlipidemic fat-loaded rats.

Authors:  F Maccari; A Arseni; P Chiodi; M T Ramacci; L Angelucci; W C Hulsmann
Journal:  Lipids       Date:  1987-12       Impact factor: 1.880

View more
  4 in total

Review 1.  Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2011-12-02       Impact factor: 5.614

2.  Obesity and lipid stress inhibit carnitine acetyltransferase activity.

Authors:  Sarah E Seiler; Ola J Martin; Robert C Noland; Dorothy H Slentz; Karen L DeBalsi; Olga R Ilkayeva; Jie An; Christopher B Newgard; Timothy R Koves; Deborah M Muoio
Journal:  J Lipid Res       Date:  2014-01-06       Impact factor: 5.922

3.  No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.

Authors:  P Pregant; E Kaiser; G Schernthaner
Journal:  Clin Investig       Date:  1993-08

4.  Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.

Authors:  Jose Luis Santiago; Alfonso Martínez; Hermenegildo de la Calle; Miguel Fernández-Arquero; M Angeles Figueredo; Emilio G de la Concha; Elena Urcelay
Journal:  BMC Med Genet       Date:  2006-06-23       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.